The Practical Evidence of Antidiabetic Combination Therapy in Korea

Summary

This study evaluate the efficacy and safety of alogliptin and pioglitazone combination therapy in comparison with either alogliptin or pioglitazone on glucose control in the metformin-treated type 2 diabetic patients in Korea.

Timeline

Start

2014-09

Primary completion

2018-10-22

Completion

2019-01-28

Drugs

Indications